Disponibili nelle farmacie nuove specialità medicinali: da Loargys a Metalyse passando per Selit e 8 nuovi farmaci equivalenti
Nuove specialità medicinali
LOARGYS 1 flaconcino EV SC 5 mg/ml 0,4 ml pegzilarginasi
IMMEDICA AIC:050980010 8.093,87€ H/RNRL in commercio dal:10/02/2025
METALYSE 1 flaconcino EV 5.000 UI tenecteplase
BOEHRINGER INGELHEIM AIC:035370079 2.407,90€ Cnn/OSP in commercio dal:17/02/2025
SELIT 20 cpr 200 mcg sodio selenito pentaidrato
BIOSYN AIC:050084019 26,00€ Cnn/RR in commercio dal:11/02/2025
Nuovi farmaci equivalenti
AMLODIPINA E VALSARTAN KRKA PHARMA 28 cpr riv 10 mg + 160 mg amlodipina besilato/valsartan
KRKA AIC:044288049 10,88€ A/RR in commercio dal:11/02/2025
EZETIMIBE E ATORVASTATINA EG STADA 30 cpr riv 10 mg + 40 mg ezetimibe/atorvastatina calcio triidrato
EG AIC:050978131 12,50€ A/RR in commercio dal:13/02/2025
FINASTERIDE ALTER 30 cpr riv 5 mg finasteride
LABORATORI ALTER AIC:038160026 12,12€ A/RR in commercio dal:17/02/2025
LACOSAMIDE TECNIGEN 56 cpr riv 150 mg lacosamide
TECNIGEN AIC:050588060 75,17€ A/RR in commercio dal:15/02/2025
LACOSAMIDE TECNIGEN 56 cpr riv 200 mg lacosamide
TECNIGEN AIC:050588072 100,23€ A/RR in commercio dal:15/02/2025
TADALAFIL PENSA PHARMA 2 cpr riv 20 mg tadalafil
TOWA AIC:048862078 19,60€ C/RR in commercio dal:17/02/2025
TAPENTADOLO KRKA 30 cpr 50 mg rilascio prolungato flacone tapentadolo maleato
KRKA AIC:049574027 8,63€ Cnn/RNR in commercio dal:13/02/2025
TEICOPLANINA ALTAN infus 1 flaconcino polv 400 mg 10 ml teicoplanina
ALTAN AIC:046457065 55,05€ H/RNRL in commercio dal:07/02/2025